REFERENCES
1. Arora A, Wetter DA, Gonzalez-Santiago TM, Davis MDP, Lohse CM. Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based Study in Olmsted County, Minnesota. Mayo Clinic Proceedings. 2014; 89( 11): 1515- 1524. doi: https:// doi. org / 10.1016 / j. mayocp. 2014.04.015
2. Kanaji N, Watanabe N, Kita N, et al. Paraneoplastic syndromes associated with lung cancer. World Journal of Clinical Oncology. 2014; 5( 3): 197-223. doi: https:// doi. org / 10.5306 / wjco. v5. i3.197
3. Solans-Laqué R, Bosch-Gil JA, Pérez- Bocanegra C, Selva-O’ Callaghan A, Simeón-Aznar CP, Vilardell-Tarres M.
Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. The Journal of rheumatology. 2008; 35( 2): 294-304.
4. Cord Sunderkötter, Golle L, Évangéline Pillebout, Michl C. Pathophysiology and clinical manifestations of immune complex vasculitides. Frontiers in Medicine. 2023; 10. doi: https:// doi. org / 10.3389 / fmed. 2023.1103065
5. Loricera J, Calvo-Río V, Ortiz-Sanjuán F, et al. The Spectrum of paraneoplastic cutaneous vasculitis in a defined population. Medicine. 2013; 92( 6): 331- 343. doi: https:// doi. org / 10.1097 / md. 0000000000000009
6. Malgorzata Potentas-Policewicz, Justyna Fijolek. Granulomatosis with polyangiitis: clinical characteristics and updates in diagnosis. Frontiers in Medicine. 2024; 11. doi: https:// doi. org / 10.3389 / fmed. 2024.1369233
7. Ertekin SS, Koku Aksu AE, Leblebici C, et al. Systemic disease in leukocytoclastic vasculitis: a focus on direct immunofluorescence findings. Anais brasileiros de dermatologia. 2023; 98( 1): 59-67. doi: https:// doi. org / 10.1016 / j. abd. 2021.11.009
8. Fraticelli P, Benfaremo D, Gabrielli A. Diagnosis and management of leukocytoclastic vasculitis. Internal and Emergency Medicine. 2021; 16( 4): 831- 841. doi: https:// doi. org / 10.1007 / s11739-021-02688-x
22 • www. wvsma. org